Mayo Foundation takes 4.3% stake in PulseAI Ltd

Published

Mayo Foundation for Medical Education and Research entered PulseAI Ltd, an AI cardiac diagnostics software firm, with ordinary shares representing a 4.3% stake.

Techstart Ventures II Limited Partnership, acting through its general partner Techstart Ventures II GP Limited, entered with ordinary shares representing a 1.8% stake.

The David W. Mortara 1988 Trust entered with ordinary shares representing a 1.1% stake.

The Francis Crick Institute Limited entered with ordinary shares representing a 1.1% stake.

Separately, Innovation Ulster Limited increased its holding to 8.4%.

The filing dated 21 September 2026 covers the multi-year period from 6 September 2023 to 25 June 2026.

Shareholder data

Source: Companies House confirmation statement (CS01) — period to , filed .

Current shareholders (5)

ShareholderTotal sharesShare classes
INNOVATION ULSTER LIMITED105,438
ORDINARY 105,438
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 200 FIRST STREET SW ROCHESTER MINNESOTA US54,003
ORDINARY 54,003
TECHSTART VENTURES II LIMITED PARTNERSHIP ACTING THROUGH ITS GENERAL PARTNER TECHSTART VENTURES II GP LIMITED22,983
ORDINARY 22,983
DAVID W. MORTARA 1988 TRUST F/BO JUSTIN L. MORTARA 2766 N SHEPARD AVENUE MILWAUKEE UNITED STATES14,143
ORDINARY 14,143
THE FRANCIS CRICK INSTITUTE LIMITED 1 MIDLAND ROAD LONDON UNITED KINGDOM14,143
ORDINARY 14,143

Share this

Contact the editorial team at editorial@fundingspotter.com